€12.76
3.40% day before yesterday
Xetra, Mar 14, 05:35 pm CET
ISIN
DE000A1MMCC8
Symbol
ILM1
Index

Medios Stock price

€12.76
+0.14 1.11% 1M
-3.58 21.91% 6M
-0.46 3.48% YTD
-1.28 9.12% 1Y
-14.79 53.68% 3Y
-10.74 45.70% 5Y
+5.26 70.13% 10Y
Xetra, Closing price Fri, Mar 14 2025
+0.42 3.40%
ISIN
DE000A1MMCC8
Symbol
ILM1
Index
Sector

Key metrics

Market capitalization €325.45m
Enterprise Value €493.78m
P/E (TTM) P/E ratio 24.21
EV/FCF (TTM) EV/FCF 19.50
EV/Sales (TTM) EV/Sales 0.27
P/S ratio (TTM) P/S ratio 0.18
P/B ratio (TTM) P/B ratio 0.64
Revenue growth (TTM) Revenue growth 5.68%
Revenue (TTM) Revenue €1.84b
EBIT (operating result TTM) EBIT €27.98m
Free Cash Flow (TTM) Free Cash Flow €25.32m
Cash position €67.60m
EPS (TTM) EPS €0.53
P/E forward 13.18
P/S forward 0.17
EV/Sales forward 0.27
Show more

Is Medios a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,808 stocks worldwide.

Medios Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Medios forecast:

6x Buy
100%

Analyst Opinions

6 Analysts have issued a Medios forecast:

Buy
100%

Financial data from Medios

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
1,842 1,842
6% 6%
100%
- Direct Costs 1,783 1,783
5% 5%
97%
59 59
14% 14%
3%
- Selling and Administrative Expenses 4.17 4.17
3,375% 3,375%
0%
- Research and Development Expense - -
-
-
55 55
7% 7%
3%
- Depreciation and Amortization 27 27
23% 23%
1%
EBIT (Operating Income) EBIT 28 28
6% 6%
2%
Net Profit 13 13
32% 32%
1%

In millions EUR.

Don't miss a Thing! We will send you all news about Medios directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Medios Stock News

AD HOC NEWS
12 days ago
Das Spezialpharma-Unternehmen Medios DE000A1MMCC8 schaut nach kräftigen Zuwächsen optimistisch in die Zukunft.
AD HOC NEWS
12 days ago
Das Spezialpharmaunternehmen Medios DE000A1MMCC8 will nach einem kräftigen Umsatz- und Gewinnanstieg weiter zulegen.
More Medios News

Company Profile

Medios AG is a holding company, which engages in the provision of pharmaceutical drugs. It operates through the following segments: Provision of Medicinal Products, Patient-specific Therapies, and Services. The Provision of Medicinal Products segment focuses on specialty pharmaceuticals means it trades almost exclusively in expensive medicinal products for chronic and/or rare diseases. The Patient-specific Therapies segment include infusions constituted and produced on the basis of individual symptoms and individual parameters such as body weight and body surface. The Services segment consists of all other Group activities, including Medios Group holding activities. The company was founded in 1980 and is headquartered in Berlin, Germany.

Head office Germany
CEO Matthias Gärtner
Employees 515
Founded 1980
Website www.medios.ag

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today